According to Actoverco Public Relations, the senior marketing and sales manager of Actero said: “Actero Pharmaceutical factory specialized in the production of cancer drugs and one of the six subcategories of Actover Holding, by the end of this year and operating its solid and injectable drugs production lines (which started in 2018) will be able to supply more than 18 drugs needed to treat common cancers in the country.”

Dr. Tiam Esfahani added: “Currently, 4 oral drugs and 5 injectable drugs of this factory are available for the patients of our country and we believe that it is the right of the dear patients to have their needed drugs with the highest quality.”

Reference: PHANA